Saturday, February 28, 2026

Vivo Cannabis Sees Majority Of Board Resign Due To “Strategic Differences”

Vivo Cannabis (TSX: VIVO) appears to be going through in-fighting in terms of the direction of the company. The firm this morning announced that a total of four directors have resigned from their role with the company, leaving just one director on the firms board. The firm has also lost its interim CEO.

The company announced that Rick Fitzgerald, whom was also interim CEO of the company until June 30, 2021 and formerly the chairman and CEO of Diageo Canada, as well as John Easson, Christie Henderson, and Daryl Kramp have resigned from their directorships. They also will not be standing for re-election at the firms shareholding meeting slated to take place today.

The move effectively leaves Roy Laflamme, whom is president of the firms Canna Farms subsidiary, as the sole director on the firms board. A new slate of directors is said to be announced after the firms meeting scheduled for today.

The departures of the firms board is said to be a result of “strategic differences” between the firms largest shareholders and the board, however the company was clear in saying that it was “not related to the Company’s financial performance, liquidity, or regulatory standing.” The firm also claims there is to be no material impact to the firms operations, despite it being unclear whom is currently acting as CEO for the company.

Vivo Cannabis last traded at $0.13 on the TSX.


Information for this briefing was found via Sedar and Vivo Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Can the World Actually Supply $6 Copper? | Greg Ferron – PTX Metals

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

Recommended

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Steadright: Atrium Research Initiates Coverage With $0.50 Price Target

Related News

Vivo Cannabis To Move To Toronto Stock Exchange

Vivo Cannabis (TSXV: VIVO) is officially moving to the big boards. The firm announced this...

Thursday, January 23, 2020, 08:16:47 AM

Vivo Cannabis Reports Q1 Revenue Of $5.5 Million, Net Loss Of $3.5 Million

VIVO Cannabis Inc. (TSX: VIVO) last night reported its Q1 2021 financial and operating results....

Tuesday, May 18, 2021, 08:33:28 AM

Canopy Growth’s Bruce Linton Finds Himself in a Catch-22

Canopy Growth Corp’s (TSX: WEED) (NYSE: CGC) Bruce Linton came under fire yesterday across social...

Friday, June 28, 2019, 09:22:46 AM

The Public Partners of Westleaf

Westleaf Inc (TSXV: WL) is a $300 million company in which we can almost guarantee...

Monday, January 28, 2019, 02:00:06 PM

MediPharm Labs, Vivo Cannabis Slump After Announcing All-Stock Deal

MediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX:...

Sunday, December 25, 2022, 01:35:00 PM